← Back to Search

Anti-metabolites

Neoadjuvant Chemo-Radiotherapy and Resection for Pancreatic Cancer

Phase 2

Waitlist Available

Led By Gazala Khan, MD

Research Sponsored by Henry Ford Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial is testing a new combination of chemotherapy drugs and radiation to see if it is more effective and has fewer side effects than the current standard of care.

Eligible Conditions

Pancreatic Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of R0 Resection

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neoadjuvant Chemo-Radiotherapy and ResectionExperimental Treatment4 Interventions

2 cycles - FOLFOX6 (1 month) Gemcitabine/RT (5-6 weeks) Rest period 2 weeks Re-staging evaluation (CT scan to be done during the 2 weeks of rest) Surgery (To be performed no later than 6 weeks after completion of chemo-radiation)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Pancreaticoduodenectomy with retroperitoneal lymphadenectomy

2014

Completed Phase 2

~30

Gemcitabine

2017

Completed Phase 3

~2070

Radiation Therapy

2017

Completed Phase 3

~7250

Folfox6

2014

Completed Phase 2

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor

300 Previous Clinical Trials

2,099,858 Total Patients Enrolled

Gazala Khan, MDPrincipal InvestigatorHenry Ford Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experimentation allow for geriatric patients?

"For this particular study, only adults aged 18 to 99 can apply. There are 327 clinical trials underway for minors and 2799 studies available for senior citizens."

Answered by AI

What is the government's official stance on this medication?

"The safety of this treatment falls in the middle of our 1 to 3 scale at 2. This is due to it being a Phase 2 trial, where there is some evidence supporting safety, but no data yet on whether or not the intervention works."

Answered by AI

Can patients sign up for this trial at the moment?

"Unfortunately, this specific clinical trial is not currently looking for patients. Although, it is important to note that there are 2992 other trials that are still recruiting individuals. This particular study was first posted on February 1st 2014 and last updated on October 13th 2016."

Answered by AI

How can I take part in this experiment?

"Eligible patients must be between 18-99 years old, have cancer of the pancreas, and meet the following additional criteria: ECOG performance status </= 1, Age >/= 18years, Life expectancy of greater than 6 months in the opinion of the investigator."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Gazala Khan, MD 2014. "Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02243358.